Galapagos | GLPG - Operating Expenses

Stock Price
29.16
Daily Change
0.26 0.90%
Monthly
6.81%
Yearly
32.43%
Q1 Forecast
27.75

Galapagos reported EUR112.83M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
argenx SE USD 776.99M 32.87M Sep/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Genmab DKK 565M 38M Jun/2025
Gilead Sciences USD 4.26B 95M Sep/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Incyte USD 4.65B 3.75B Sep/2025
Merck EUR 4.11B 117M Sep/2025
Neurocrine Biosciences USD 555.6M 13.7M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024
Vertex Pharmaceuticals USD 1.84B 27.1M Sep/2025